Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
Best-selling author Buzz Bissinger has relived the birth of his twin sons for nearly three decades. Gerry came first, weighing just over two pounds. But Zach, born three minutes later, suffered brain damage from a lack of oxygen. Gerry had no serious complications –- he became a teacher and is studying to earn a PhD. Zach bags groceries and will likely do so for the rest of his life. But while Zach accepted his 8-year-old comprehension skills, his father struggled to do the same. Buzz’s youngest twin remained a mystery to him until the two men took a cross-country road trip together. Diane and her guest discuss how he found peace with the fact that his son will never grow up.
- Buzz Bissinger author of "Friday Night Lights"
Read An Excerpt
Excerpted from FATHER’S DAY: A Journey into the Mind and Heart of My Extraordinary Son by Buzz Bissinger. Copyright © 2012 by H.G. Bissinger. Used by permission of Houghton Mifflin Harcourt. All rights reserved.
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.